XtalPi Holdings Ltd
2228
Classement en actions
#4645
XtalPi Holdings Limited functions as an investment holding company, delivering... XtalPi Holdings Limited functions as an investment holding company, delivering sophisticated drug discovery and intelligent automation solutions across key markets including China, the United States, Europe, South Korea, and Japan. Its comprehensive drug discovery services encompass the entire research and development process, ranging from target validation and hit identification to lead generation, lead optimization, and PCC nomination. These services are adept across diverse therapeutic modalities, such as small molecules, antibodies, peptides, ADCs, and PROTACs. The company's intelligent automation solutions specifically utilize artificial intelligence and automation to facilitate the accelerated discovery and research of novel drugs and materials. Established in 2015 and based in Shenzhen, China, the firm was formerly known as QuantumPharm Inc. before officially changing its name to XtalPi Holdings Limited in December 2024.
Prix de l'action
$0.74616501
Capitalisation boursière
$3.21B
Changement (1 jour)
-4.10%
Changement (1 an)
-50.36%
Pays
CN
Échange XtalPi Holdings Ltd (2228)
Catégorie
Healthcare
Ratio P/B pour XtalPi Holdings Ltd (2228)
Ratio P/B au October 2026 TTM : 2.26
Selon les derniers rapports financiers et le cours de l'action de XtalPi Holdings Ltd, le ratio cours/valeur comptable actuel (TTM) est 2.26. À la fin de 2024, le ratio P/B était de 2.72.
Historique du ratio P/B pour XtalPi Holdings Ltd de 2024 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 2.26 | -33.91% |
| 2025 | 3.42 | 25.85% |
| 2024 | 2.72 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 6.251 | 176.56% |
US
|
|
| 13.6307 | 503.05% |
US
|
|
| 4.4521 | 96.97% |
AU
|
|
| 3.2932 | 45.70% |
BE
|
|
| 6.3632 | 181.52% |
NL
|
